Dashboard
1
With a growth in Net Profit of 322.01%, the company declared Outstanding results in Sep 25
- The company has declared positive results in Jan 70 after 2 consecutive negative quarters
- OPERATING CASH FLOW(Y) Highest at CNY 52.72 MM
- NET PROFIT(HY) Higher at CNY 17.19 MM
- INVENTORY TURNOVER RATIO(HY) Highest at 2.43 times
2
With ROE of 0.76%, it has a very expensive valuation with a 3.83 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
CNY 1,600 Million (Small Cap)
503.00
NA
0.28%
-0.33
3.99%
1.50
Revenue and Profits:
Net Sales:
220 Million
(Quarterly Results - Mar 2026)
Net Profit:
16 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.89%
0%
1.89%
6 Months
5.08%
0%
5.08%
1 Year
30.9%
0%
30.9%
2 Years
37.42%
0%
37.42%
3 Years
9.8%
0%
9.8%
4 Years
-4.61%
0%
-4.61%
5 Years
-15.28%
0%
-15.28%
Boji Medical Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
24.56%
EBIT Growth (5y)
-167.65%
EBIT to Interest (avg)
9.76
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.70
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
16.33%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.35%
ROE (avg)
4.53%
Valuation key factors
Factor
Value
P/E Ratio
503
Industry P/E
Price to Book Value
3.83
EV to EBIT
-1041.91
EV to EBITDA
148.40
EV to Capital Employed
4.83
EV to Sales
4.73
PEG Ratio
NA
Dividend Yield
0.11%
ROCE (Latest)
-0.46%
ROE (Latest)
0.76%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
220.20
138.90
58.53%
Operating Profit (PBDIT) excl Other Income
17.30
11.20
54.46%
Interest
0.30
0.50
-40.00%
Exceptional Items
0.80
0.50
60.00%
Consolidate Net Profit
16.10
4.70
242.55%
Operating Profit Margin (Excl OI)
78.80%
8.20%
7.06%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 58.53% vs -17.03% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 242.55% vs -72.83% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
865.30
739.20
17.06%
Operating Profit (PBDIT) excl Other Income
52.30
38.50
35.84%
Interest
1.90
3.40
-44.12%
Exceptional Items
1.50
1.10
36.36%
Consolidate Net Profit
32.90
30.70
7.17%
Operating Profit Margin (Excl OI)
19.50%
10.20%
0.93%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 17.06% vs 33.38% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 7.17% vs 12.87% in Dec 2024
About Boji Medical Technology Co., Ltd. 
Boji Medical Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






